Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA )

CompletedOBSERVATIONAL
Enrollment

98

Participants

Timeline

Start Date

December 16, 2016

Primary Completion Date

March 11, 2020

Study Completion Date

March 11, 2020

Conditions
Crohn's Disease
Trial Locations (24)

T2N 4Z6

University of Calgary /ID# 157893, Calgary

T6L 6K3

South Edmonton Gastroenterolog /ID# 170934, Edmonton

V3L 3W5

Columbia Gastro Mgmnt Ltd /ID# 152507, New Westminster

V6Z 2K5

GIRI Gastrointestinal Research Institute /ID# 201259, Vancouver

V8T 5G4

Discovery Clinical Services /ID# 154682, Victoria

V8V 3M9

Percuro Clinical Research, Ltd /ID# 202502, Victoria

R3A 1R9

Winnipeg Regional Health Autho /ID# 200115, Winnipeg

E3B 5N5

Dr. Everett Chalmers Reg Hosp. /ID# 171560, Fredericton

B3H 1V7

Qe Ii Hsc /Id# 152454, Halifax

N1R 0B6

Dr. Mark Lee Medicine Professi /ID# 153127, Cambridge

L8S 4K1

McMaster University Med Cent /ID# 151996, Hamilton

N6A 5A5

London Health Sciences Centre /ID# 152508, London

L6M 4J2

Jeffrey So Medicine Professional Corporation /ID# 168268, Oakville

L1H 7K4

Taunton surgical centre /ID# 151998, Oshawa

K1H 8L6

The Ottawa Hospital /ID# 153771, Ottawa

M5G 1X5

Mount Sinai Hosp.-Toronto /ID# 155262, Toronto

N8W 1E6

Dr O Tarabain Medicine Prof Corp /ID# 163125, Windsor

J4V 2H1

CISSS de la Monteregie /ID# 162724, Greenfield Park

G6V 3Z1

Hopital Hotel-Dieu de Levis /ID# 155493, Lévis

H1T 2M4

Hospital Maisonneuve-Rosemont /ID# 155184, Montreal

H3G 1A4

McGill Univ HC /ID# 151997, Montreal

H3P 3E5

Clinique MEDI-CLE /ID# 153772, Montreal

J1G 2E8

CIUSSS de l'Estrie - CHUS /ID# 157976, Sherbrooke

S7N 0W8

Royal Uni Saskatchew(CTSU) /ID# 162316, Saskatoon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY